Trial intelligence / Profile preview

Optimization of Transfusion Use and Correction of Iron Deficiencies in Cardiac Surgery

NCT04040023Completed

Sponsor
Clinique Pasteur
Start
Sep 2019
Primary completion
Jul 2021
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Open-label trial of Iron, folic acid, vitamin b12 and erythropoietin (2 arms), sponsored by Clinique Pasteur. Primary endpoint: Red Blood Cell Transfusion Rate. Started Sep 2019; status: completed.

02

Drugs

Ironfolic acidvitamin b12erythropoietin

Beyond the preview

Go deeper on NCT04040023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04040023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call